[This Week's IPO] Book-Building and Subscription Schedule for the Second Week of November

In the second week of November, AimedBio and Teraview Holdings will conduct book-building for institutional investors. CMTX and Vitronextech are preparing for their public subscription offerings.

<Book-Building>

◆AimedBio= AimedBio was established in 2018 as a spin-off from Samsung Medical Center. The company has developed an ADC new drug development platform based on unmet clinical needs and is currently developing a pipeline with enhanced clinical predictability and applicability.

A total of 6.43 million shares will be offered. The desired offering price is between 9,000 and 11,000 KRW, and the book-building will take place from November 12 to 18. After receiving public subscriptions from November 21 to 24, the company plans to list on the KOSDAQ market. The underwriter is Mirae Asset Securities.

◆Teraview Holdings= Teraview Holdings possesses terahertz technology and solutions used for ultra-precision inspection in advanced industries. Terahertz is an electromagnetic wave with a frequency of 1 trillion Hz. It is harmless to the human body and reflects the intrinsic properties of materials, allowing for simultaneous analysis of various parameters such as thickness, density, and conductivity.

A total of 5 million KDRs (Korea Depositary Receipts) will be offered. The desired offering price range is between 7,000 and 8,000 KRW. Book-building will take place from November 13 to 19, and public subscription will be held from November 24 to 25. The underwriter is Samsung Securities.

<Public Subscription>

◆CMTX= The offering price has been set at the upper end of the desired range, 60,500 KRW. A total of 2,423 domestic and international institutions participated in the book-building, resulting in a competition rate of 756.19 to 1. Public subscription will be held over two days, November 10 and 11, with the goal of listing on the KOSDAQ market on November 20. Mirae Asset Securities is the lead underwriter.

Since its establishment in 2013, CMTX has expanded its business from ceramic and sapphire components for semiconductor etching processes to key consumable silicon components such as silicon rings and electrodes. The company is the only one in Korea with a fully integrated vertical system capable of handling the entire process from silicon ingot production to final parts manufacturing in-house.

◆Vitronextech= The desired offering price is between 5,900 and 6,900 KRW. The expected market capitalization is between 171 billion and 199.9 billion KRW. Book-building was completed by November 6, and public subscription will be held over two days, November 11 and 12. NH Investment & Securities and Kyobo Securities are the lead underwriters.

Vitronextech was established in 2016 through a physical spin-off from the special business division of Vitrotech, and its core businesses are in advanced scientific applications such as aerospace, nuclear fusion, accelerators, and plasma. As of last year, the company recorded sales of 30.4 billion KRW and an operating loss of 14 billion KRW.

This content was produced with the assistance of AI translation services.